Sectoral Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$677K	Buy	79,150 +49,347	+166%	+$473K	0.56%	48
2025 Q4	$347K	Sell	29,803 -51,982	-64%	-$506K	0.28%	66
2025 Q3	$822K	Buy	81,785 +16,000	+24%	+$230K	0.51%	56
2025 Q2	$1.15M	Sell	65,785 -34,420	-34%	-$497K	0.76%	45
2025 Q1	$1.26M	Sell	100,205 -5,802	-5%	-$69.8K	0.98%	27
2024 Q4	$1.12M	Buy	106,007 +7,367	+7%	+$103K	0.75%	38
2024 Q3	$1.43M	Sell	98,640 -138,297	-58%	-$1.64M	0.84%	38
2024 Q2	$2.02M	Buy	236,937 +32,500	+16%	+$288K	0.82%	37
2024 Q1	$2.09M	Sell	204,437 -150,204	-42%	-$1.12M	0.82%	38
2023 Q4	$1.94M	Sell	354,641 -694,550	-66%	-$3.04M	0.84%	46
2023 Q3	$3.97M	Sell	1,049,191 -206,449	-16%	-$1.36M	0.77%	56
2023 Q2	$8.41M	Buy	1,255,640 +462,053	+58%	+$3.08M	1.4%	23
2023 Q1	$5.17M	Buy	793,587 +11,177	+1%	+$85.9K	0.99%	45
2022 Q4	$6.67M	Sell	782,410 -262,824	-25%	-$1.71M	1.29%	26
2022 Q3	$5.52M	Buy	+1,045,234	New	+$5.15M	1.09%	38